β-estradiol (E2) stimulates synthesis of cyclic ADP ribose (cADPR) in rat uterus

Eduardo Nunes Chini, F. G S De Toledo, T. P. Dousa

Research output: Contribution to journalArticle

Abstract

Administration of E2 is known to increase sensitivity of myometrium to contractile stimuli, that are mediated by an increase of intracellular Ca2 (Cai 2+). Recently discovered nucleotide, cADPR, was shown to promote smooth muscle contraction. We investigated whether administration of E2 to ovarectomized (OVX) rats changes activity of ADP-ribose cyclase, an enzyme that catalyzes synthesis of cADPR from β-NAD in uterus. OVX rats were injected with E2 (200 μg/kg/day for 7 days, s.c.), and ADPR cyclase activity was determined in homogenates from uterus by measurement of cADPR synthesis from β-NAD. In uteri from E2-rats cADPR synthesis was greatly (> Δ + 300%) increased. cADPR (nmol/mg protein); mean ± SEM controls: 1.5 ± 0.1 (4); E2-treated: 6.5 ± 0.5(4); (P < 0.05) Authenticity of cADPR product was verified with the use of sea urchin homogenate bioassays. Tamoxifen, E2-receptor antagonist (8 mg/kg/day), blocked stimulatory effect of E2 upon uterine ADPR-cyclase. Conclusions: a) E2 stimulates, via action on its receptor, activity of ADPR-cyclase in uterus; b) E2 is the first hormone found to increase cADPR synthesis in vivo; c) we surmise that increased cADPR generation caused by E2 may be the main or contributing factor that accounts for enhanced Cai 2+ release and contractility of uterus in response to oxytocin and prostaglandin F.

Original languageEnglish (US)
JournalFASEB Journal
Volume11
Issue number3
StatePublished - 1997

Fingerprint

Cyclic ADP-Ribose
ribose
uterus
Uterus
estradiol
Rats
Estradiol
ADP-ribosyl Cyclase
synthesis
rats
NAD
Dinoprost
myometrium
Sea Urchins
tamoxifen
Myometrium
Bioassay
cyclic nucleotides
receptors
Oxytocin

ASJC Scopus subject areas

  • Agricultural and Biological Sciences (miscellaneous)
  • Biochemistry, Genetics and Molecular Biology(all)
  • Biochemistry
  • Cell Biology

Cite this

β-estradiol (E2) stimulates synthesis of cyclic ADP ribose (cADPR) in rat uterus. / Chini, Eduardo Nunes; De Toledo, F. G S; Dousa, T. P.

In: FASEB Journal, Vol. 11, No. 3, 1997.

Research output: Contribution to journalArticle

@article{326f6f034ba941528c38dc678a7fa276,
title = "β-estradiol (E2) stimulates synthesis of cyclic ADP ribose (cADPR) in rat uterus",
abstract = "Administration of E2 is known to increase sensitivity of myometrium to contractile stimuli, that are mediated by an increase of intracellular Ca2 (Cai 2+). Recently discovered nucleotide, cADPR, was shown to promote smooth muscle contraction. We investigated whether administration of E2 to ovarectomized (OVX) rats changes activity of ADP-ribose cyclase, an enzyme that catalyzes synthesis of cADPR from β-NAD in uterus. OVX rats were injected with E2 (200 μg/kg/day for 7 days, s.c.), and ADPR cyclase activity was determined in homogenates from uterus by measurement of cADPR synthesis from β-NAD. In uteri from E2-rats cADPR synthesis was greatly (> Δ + 300{\%}) increased. cADPR (nmol/mg protein); mean ± SEM controls: 1.5 ± 0.1 (4); E2-treated: 6.5 ± 0.5(4); (P < 0.05) Authenticity of cADPR product was verified with the use of sea urchin homogenate bioassays. Tamoxifen, E2-receptor antagonist (8 mg/kg/day), blocked stimulatory effect of E2 upon uterine ADPR-cyclase. Conclusions: a) E2 stimulates, via action on its receptor, activity of ADPR-cyclase in uterus; b) E2 is the first hormone found to increase cADPR synthesis in vivo; c) we surmise that increased cADPR generation caused by E2 may be the main or contributing factor that accounts for enhanced Cai 2+ release and contractility of uterus in response to oxytocin and prostaglandin F2α.",
author = "Chini, {Eduardo Nunes} and {De Toledo}, {F. G S} and Dousa, {T. P.}",
year = "1997",
language = "English (US)",
volume = "11",
journal = "FASEB Journal",
issn = "0892-6638",
publisher = "FASEB",
number = "3",

}

TY - JOUR

T1 - β-estradiol (E2) stimulates synthesis of cyclic ADP ribose (cADPR) in rat uterus

AU - Chini, Eduardo Nunes

AU - De Toledo, F. G S

AU - Dousa, T. P.

PY - 1997

Y1 - 1997

N2 - Administration of E2 is known to increase sensitivity of myometrium to contractile stimuli, that are mediated by an increase of intracellular Ca2 (Cai 2+). Recently discovered nucleotide, cADPR, was shown to promote smooth muscle contraction. We investigated whether administration of E2 to ovarectomized (OVX) rats changes activity of ADP-ribose cyclase, an enzyme that catalyzes synthesis of cADPR from β-NAD in uterus. OVX rats were injected with E2 (200 μg/kg/day for 7 days, s.c.), and ADPR cyclase activity was determined in homogenates from uterus by measurement of cADPR synthesis from β-NAD. In uteri from E2-rats cADPR synthesis was greatly (> Δ + 300%) increased. cADPR (nmol/mg protein); mean ± SEM controls: 1.5 ± 0.1 (4); E2-treated: 6.5 ± 0.5(4); (P < 0.05) Authenticity of cADPR product was verified with the use of sea urchin homogenate bioassays. Tamoxifen, E2-receptor antagonist (8 mg/kg/day), blocked stimulatory effect of E2 upon uterine ADPR-cyclase. Conclusions: a) E2 stimulates, via action on its receptor, activity of ADPR-cyclase in uterus; b) E2 is the first hormone found to increase cADPR synthesis in vivo; c) we surmise that increased cADPR generation caused by E2 may be the main or contributing factor that accounts for enhanced Cai 2+ release and contractility of uterus in response to oxytocin and prostaglandin F2α.

AB - Administration of E2 is known to increase sensitivity of myometrium to contractile stimuli, that are mediated by an increase of intracellular Ca2 (Cai 2+). Recently discovered nucleotide, cADPR, was shown to promote smooth muscle contraction. We investigated whether administration of E2 to ovarectomized (OVX) rats changes activity of ADP-ribose cyclase, an enzyme that catalyzes synthesis of cADPR from β-NAD in uterus. OVX rats were injected with E2 (200 μg/kg/day for 7 days, s.c.), and ADPR cyclase activity was determined in homogenates from uterus by measurement of cADPR synthesis from β-NAD. In uteri from E2-rats cADPR synthesis was greatly (> Δ + 300%) increased. cADPR (nmol/mg protein); mean ± SEM controls: 1.5 ± 0.1 (4); E2-treated: 6.5 ± 0.5(4); (P < 0.05) Authenticity of cADPR product was verified with the use of sea urchin homogenate bioassays. Tamoxifen, E2-receptor antagonist (8 mg/kg/day), blocked stimulatory effect of E2 upon uterine ADPR-cyclase. Conclusions: a) E2 stimulates, via action on its receptor, activity of ADPR-cyclase in uterus; b) E2 is the first hormone found to increase cADPR synthesis in vivo; c) we surmise that increased cADPR generation caused by E2 may be the main or contributing factor that accounts for enhanced Cai 2+ release and contractility of uterus in response to oxytocin and prostaglandin F2α.

UR - http://www.scopus.com/inward/record.url?scp=33750152667&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33750152667&partnerID=8YFLogxK

M3 - Article

VL - 11

JO - FASEB Journal

JF - FASEB Journal

SN - 0892-6638

IS - 3

ER -